Ayala Pharmaceuticals Inc.のRPEは11.111k$です。
従業員1人当たりの収益（RPE）は、収益を組織の従業員の数で割ったものです。
advaxis (nasdaq: adxs) is a late -stage biotechnology company developing multiple cancer immunotherapies based on its proprietary platform that redirects the immune system to kill cancer. the advaxis technology, using bioengineered live attenuated bacteria, listeria monocytogenes (lm), actively suppresses key components in the tumor microenvironment that contribute to the tumors growth and protection from immunologic attack.